Additionally, the inflammation and stress induced by pathological Aβ deposition may alter ApoAI's antioxidant and anti‐atherosclerotic properties, leading to vascular dysfunction, which is also associated with AD progression [64, 65, 66, 67, 68]. Here, APOA1 is linked to Alzheimer disease.